Recessive Symptomatic Focal Epilepsy and Mutant Contactin-Associated Protein-like 2
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Contactin-associated protein-like 2 (CASPR2) is encoded by CNTNAP2 and clusters voltage-gated potassium channels (K(v)1.1) at the nodes of Ranvier. We report a homozygous mutation of CNTNAP2 in Old Order Amish children with cortical dysplasia, focal epilepsy, relative macrocephaly, and diminished deep-tendon reflexes. Intractable focal seizures began in early childhood, after which language regression, hyperactivity, impulsive and aggressive behavior, and mental retardation developed in all children. Resective surgery did not prevent the recurrence of seizures. Temporal-lobe specimens showed evidence of abnormalities of neuronal migration and structure, widespread astrogliosis, and reduced expression of CASPR2.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In this neurodevelopmental phase, Caspr2, the protein encoded by CNTNAP2, is thought to assist in interactions important for cellular migration and subsequent laminar organization, indicating a role for CNTNAP2 in the construction of neural circuits (Strauss et al. 2006).”
From Dysfunctional Autism Risk Genes Cause Circuit-Specific Connectivity Deficits With Distinct Developmental Trajectories (2018) · cites this paper as Strauss et al. 2006
In the citing paper
“Furthermore, temporal lobe sections from human subjects lacking Cntnap2 display abnormal patterns of neuronal migration (Strauss et al., 2006).”
From CNVs: Harbingers of a Rare Variant Revolution in Psychiatric Genetics (2012) · cites this paper as Strauss et al., 2006
In the citing paper
“In the syndromic cases where genetic information was assessed, cases were rarely separated based on presence or absence of ASD or only qualitative neuropathology was provided [128, 340].”
From Autism spectrum disorder: neuropathology and animal models (2017) · cites this paper as [340]
Citations
Cites
Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy
de Lanerolle, N. C., Kim, J. H., Robbins, R. J., & Spencer, D. D. (1989) · Brain Research · doi:10.1016/0006-8993(89)90234-5 · Cited by 927
Kindling and status epilepticus models of epilepsy: rewiring the brain
Morimoto, K., Fahnestock, M., & Racine, R. J. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.03.009 · Cited by 838
An astrocytic basis of epilepsy
Tian, G.-F., Azmi, H., Takano, T., Xu, Q., Peng, W., Lin, J., Oberheim, N., Lou, N., Wang, X., Zielke, H. R., et al. (2005) · Nature Medicine · doi:10.1038/nm1277 · Cited by 806
The local differentiation of myelinated axons at nodes of Ranvier
Poliak, S., & Peles, E. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1253 · Cited by 625
Deletion of the KV1.1 Potassium Channel Causes Epilepsy in Mice
Smart, S. L., Lopantsev, V., Zhang, C. L., Robbins, C. A., Wang, H., Chiu, S. Y., Schwartzkroin, P. A., Messing, A., & Tempel, B. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)81018-1 · Cited by 599
Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1
Poliak, S., Salomon, D., Elhanany, H., Sabanay, H., Kiernan, B., Pevny, L., Stewart, C. L., Xu, X., Chiu, S.-Y., Shrager, P., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305018 · Cited by 564
(2000) · Elsevier eBooks · doi:10.1016/b978-0-12-065310-2.x5000-0 · Cited by 472
Zuberi, S. M. (1999) · Brain · doi:10.1093/brain/122.5.817 · Cited by 366
T HE B IOLOGY OF E PILEPSY G ENES
Noebels, J. L. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081210 · Cited by 296
Clinical disorders of brain plasticity
Johnston, M. V. (2004) · Brain and Development · doi:10.1016/s0387-7604(03)00102-5 · Cited by 274
Cited by
Items 201–300 of 657
Cntnap2 Knockout Rats and Mice Exhibit Epileptiform Activity and Abnormal Sleep–Wake Physiology
Thomas, A. M., Schwartz, M. D., Saxe, M., & Kilduff, T. S. (2016) · SLEEP · doi:10.1093/sleep/zsw026 · Cited by 67
“Trouble falling asleep, midnight awakenings, and early morning avakenings indicate involvement of the circadian system in ASD.”
BackgroundInfluentialImplications of genetic diagnostics in epilepsy surgery candidates: A single‐center cohort study
Sanders, M. W. C. B., Lemmens, C. M. C., Jansen, F. E., Brilstra, E. H., Koeleman, B. P. C., Braun, K. P. J., & (LWEC), T. D. C. E. S. P. (2019) · Epilepsia Open · doi:10.1002/epi4.12366 · Cited by 63
Composition, assembly, and maintenance of excitable membrane domains in myelinated axons
Rasband, M. N. (2011) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2010.09.010 · Cited by 59
“The functions of these CAMs in the AIS is unknown, but mutations in Caspr2 lead to epilepsies and mental retardation, and have been linked to autism [44-46].”
BackgroundScott, K. E., Kazazian, K., Mann, R. S., Möhrle, D., Schormans, A. L., Schmid, S., & Allman, B. L. (2020) · Autism Research · doi:10.1002/aur.2364 · Cited by 68
Fernandez, T. V., Morgan, T. M., Davis, N., Klin, A. J., Morris, A., Farhi, A., Lifton, R. P., & State, M. W. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.04.021 · Cited by 66
HLA Immune Function Genes in Autism
Torres, A. R., Westover, J. B., & Rosenspire, A. J. (2012) · Autism Research and Treatment · doi:10.1155/2012/959073 · Cited by 56
Disrupted AMPA Receptor Function upon Genetic- or Antibody-Mediated Loss of Autism-Associated CASPR2
Fernandes, D., Santos, S. D., Coutinho, E., Whitt, J. L., Beltrão, N., Rondão, T., Leite, M. I., Buckley, C. J., Lee, H., & Carvalho, A. L. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz032 · Cited by 67
“One such gene is CNTNAP2, in which several diseaseassociated mutations have been identified (Verkerk et al. 2003; Strauss et al. 2006; Belloso et al. 2007; Alarcon et al. 2008; Arking et al. 2008; Bakkaloglu et al. 2008; Friedman et al. 2008; Vernes et al. 2008; Zweier et al. 2009; O’Dushlaine et al. 2011; Smogavec et…”
BackgroundJang, W. E., Park, J. H., Park, G., Bang, G., Na, C. H., Kim, J. Y., Kim, K.-Y., Kim, K. P., Shin, C. Y., An, J., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01822-1 · Cited by 61
“Genetic defects to Contactin-associated protein-like 2 (CNTNAP2) can cause many neurological disabilities in humans, including ASD and intellectual disability [10, 11].”
BackgroundDo Neuronal Autoantibodies Cause Psychosis? A Neuroimmunological Perspective
Coutinho, E., Harrison, P. J., & Vincent, A. C. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.040 · Cited by 65
Toma, C., Hervas, A., Torrico, B., Balmaña, N., Salgado, M., Maristany, M., Vilella, E., Martínez‐Leal, R., Planelles, M. I., Cuscó, I., et al. (2012) · Psychiatric Genetics · doi:10.1097/ypg.0b013e32835d6fc6 · Cited by 64
“Recently, a homozygous mutation in CNTNAP2 has been reported in Old Order Amish children from several families with seizures, language regression, and pervasive developmental disorder (Strauss et al., 2006).”
BackgroundDisruption of the epigenetic code: An emerging mechanism in mental retardation
van Bokhoven, H., & Kramer, J. M. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.010 · Cited by 55
Coutinho, E., Menassa, D. A., Jacobson, L. W., West, S. J., Domingos, J., Moloney, T. C., Lang, B., Harrison, P. J., Bennett, D., Bannerman, D. M., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1751-5 · Cited by 62
“CASPR2 is clearly important in neuronal migration, as highlighted by the occurrence of cortical dysplasia in patients with an autism spectrum disorder and epilepsy due to CNTNAP2 (the gene encoding for CASPR2) homozygous mutations [33].”
BackgroundPrem, S., Millonig, J. H., & DiCicco-Bloom, E. M. (2020) · Advances in neurobiology · doi:10.1007/978-3-030-45493-7_5 · Cited by 68
Kanner, A. M., Scharfman, H. E., Jetté, N., Anagnostou, E. A., Bernard, C., Camfield, C., CAMFIELD, P. R., Legg, K. T., Dinstein, I., Giacobbe, P., et al. (2017) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2017.09.014 · Cited by 60
CNTNAP2 stabilizes interneuron dendritic arbors through CASK
Gao, R., Piguel, N. H., Melendez-Zaidi, A. E., Martin‐de‐Saavedra, M. D., Yoon, S., Forrest, M. P., Myczek, K., Zhang, F. G., Russell, T. A., Csernansky, J. G., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0027-3 · Cited by 62
“Temporal-lobe specimens of these patients showed abnormalities of neuronal structure [25].”
Genetic mechanisms of regression in autism spectrum disorder
Tammimies, K. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.04.022 · Cited by 65
Smogavec, M., Cleall, A., Hoyer, J., Lederer, D., Nassogne, M.-C., Palmer, E. E., Deprez, M., Benoit, V., Maystadt, I., Noakes, C., et al. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-103880 · Cited by 56
Epigenetic Mechanisms in Autism Spectrum Disorder
Zhubi, A., Cook, E. H., Guidotti, A., & Grayson, D. R. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801311-3.00006-8 · Cited by 60
“, 2006), and cortical dysplasia–focal epilepsy syndrome (CNTNAP2; Strauss et al., 2006).”
BackgroundSherman, E. A., Strauss, K. A., Tortorelli, S., Bennett, M. J., Knerr, I., Morton, D. H., & Puffenberger, E. G. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.09.018 · Cited by 56
Self-citationInherited genetic variants in autism-related CNTNAP2 show perturbed trafficking and ATF6 activation
Falivelli, G., Jaco, A. D., Favaloro, F. L., Kim, H.-G., Wilson, J., Dubi, N., Ellisman, M. H., Abrahams, B. S., Taylor, P., & Comoletti, D. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds320 · Cited by 59
Oxytocin in animal models of autism spectrum disorder
Peñagarikano, O. (2017) · Developmental Neurobiology · doi:10.1002/dneu.22449 · Cited by 54
“…in an Old Order Amish family with a syndromic form of autism that was named Cortical Dysplasia and Focal Epilepsy syndrome, a neuronal migration disorder characterized by epileptic seizures, hyperactivity and language regression and, in about 70% of the individuals, autism (Strauss et al., 2006).”
BackgroundClustered K+ channel complexes in axons
Rasband, M. N. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.08.081 · Cited by 50
“It is interesting to note that mutations in the Kv1 channel interacting protein Caspr2 leads to a variety of CNS abnormalities including epilepsy, mental retardation, Tourette syndrome, and Autism Spectrum Disorder [1,49,59].”
BackgroundCurrent perspectives in autism spectrum disorder: from genes to therapy
Chahrour, M., O'Roak, B. J., Santini, E., Samaco, R. C., Kleiman, R. J., & Manzini, M. C. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2335-16.2016 · Cited by 54
“Examples of ASD genes with recessive LoF mutations identified in families with autism, intellectual disability (ID), and epilepsy include: CNTNAP2 (Strauss et al., 2006), SLC9A9/NHE9 (Morrow et al.”
BackgroundAmiet, C., Gourfinkel-An, I., Laurent, C., Bodeau, N., Génin, B., Leguern, E., Tordjman, S., & Cohen, D. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-47 · Cited by 52
“CNTNAP2 7q35 Deletion Recessive inheritance ASD, E, ID, SCZ Synapse formation [49-51]”
Oxytocin as a Modulator of Synaptic Plasticity: Implications for Neurodevelopmental Disorders
Rajamani, K. T., Wagner, S., Grinevich, V., & Harony-Nicolas, H. (2018) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2018.00017 · Cited by 53
“Notably, subjects with PWS have a significantly decreased number of PVN-OXT neurons and decreased levels of circulating OXT (Swaab et al., 1995; Hæybye, 2004).”
BackgroundClinical manifestations of patients with CASPR2 antibodies
Sunwoo, J., Lee, S., Byun, J., Moon, J., Shin, J.-W., Jeong, D.-E., Lee, G.-H., Jeong, S. H., Shin, Y., Jung, K., et al. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.03.005 · Cited by 58
“…of CASPR2-antibody positive patients to immunotherapy and the results demonstrating that genetic mutation of CASPR2 gene recapitulated some features of CASPR2 antibodies-associated syndromes support the pathogenic role of CASPR2 autoantibodies (Strauss et al., 2006; Penagarikano et al., 2011).”
BackgroundResultMutant Mouse Models of Autism Spectrum Disorders
Provenzano, G., Zunino, G., Genovesi, S., Sgadó, P., & Bozzi, Y. (2012) · Disease Markers · doi:10.1155/2012/916082 · Cited by 59
Chen, J., Calhoun, V. D., Pearlson, G. D., Perrone‐Bizzozero, N. I., Sui, J., Turner, J. A., Bustillo, J., Ehrlich, S., Sponheim, S. R., Cañive, J. M., et al. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.05.073 · Cited by 52
“interactions during latter phases of neuroblast migration and laminar organization (Strauss et al., 2006).”
BackgroundStudying Autism in Rodent Models: Reconciling Endophenotypes with Comorbidities
Argyropoulos, A., Gilby, K. L., & Hill‐Yardin, E. L. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00417 · Cited by 52
“The CNTNAP2 gene has been associated with ASD and a recessive form of epilepsy (Strauss et al., 2006).”
BackgroundToma, C., Pierce, K. D., Shaw, A. D., Heath, A., Mitchell, P. B., Schofield, P. R., & Fullerton, J. M. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007535 · Cited by 54
Peripheral Somatosensory Neuron Dysfunction: Emerging Roles in Autism Spectrum Disorders
Orefice, L. L. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.01.039 · Cited by 54
“Humans with homozygous, loss-of-function mutations in the Cntnap2 gene, which encodes for contactin-associated protein-like 2 (CASPR2), exhibit developmental delays and a number of core ASD features in addition to somatosensory abnormalities, pain hypersensitivity and peripheral neuron hyperexcitability (Masood and Si…”
BackgroundGene associated with seizures, autism, and hepatomegaly in an Amish girl
Jackman, C., Horn, N. D., Molleston, J. P., & Sokol, D. K. (2009) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2008.10.013 · Cited by 50
“These findings led the authors to describe a cortical dysplasia–focal epilepsy syndrome as the neuropathologic phenotype associated with the CNTNAP2 mutation [1].”
BackgroundInfluentialNon‐syndromic language delay in a child with disruption in the Protocadherin11X/Y gene pair
Speevak, M. D., & Farrell, S. A. (2011) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31186 · Cited by 53
“…found to be responsible for the dominant inheritance pattern of a Specific Language Impairment (SLI) disorder in one family [Lai et al., 2001] and mutations in CNTNAP2, a target of FOXP2, were found in a group of Amish children with, among other deficits, language regression [Strauss et al., 2006].”
BackgroundAmarillo, I. E., Li, W. L., Li, X., Vilain, E. J. N., & Kantarci, S. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36393 · Cited by 53
“…involved inproperperipheral nervous system (PNS) development and reported to interact with Contactin 2, a protein also expressed in the PNS. CNTNAP2 mutations are associated cortical dysplasia-focal epilepsy syndrome [Strauss et al., 2006] and Gilles de la Tourette syndrome [Verkerk et al., 2003].”
BackgroundCNTNAP2 and Language Processing in Healthy Individuals as Measured with ERPs
Kos, M., van den Brink, D., Snijders, T. M., Rijpkema, M., Franke, B., Fernández, G., & Hagoort, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046995 · Cited by 54
“It has been related to impaired speech development in Pitt-Hopkins-like syndrome involving intellectual disability [22,23], to language regression in recessive symptomatic focal epilepsy [24], and to delays in language acquisition [25,26], semantic-pragmatic skills [26] and speech [27] in autism.”
BackgroundHypothalamic Neuropeptide Brain Protection: Focus on Oxytocin
Panaro, M. A., Benameur, T., & Porro, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051534 · Cited by 54
Panaitof, S. C., Abrahams, B. S., Dong, H., Geschwind, D. H., & White, S. A. (2010) · Journal of Comparative Neurology · doi:10.1002/cne.22318 · Cited by 49
“…syndrome (Verkerk et al., 2003), schizophrenia (Friedman et al., 2007), attention-deficit hyperactivity disorder (Elia et al., 2009), cortical dysplasia-focal epilepsy syndrome (Strauss et al., 2006; Jackman et al., 2009) and intellectual disability (Zweier et al., 2009; Poot et al., 2009).”
BackgroundInfluentialImaging-Genetics in Autism Spectrum Disorder: Advances, Translational Impact, and Future Directions
Ameis, S. H., & Szatmari, P. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00046 · Cited by 45
Intragenic CNTNAP2 Deletions: A Bridge Too Far
Poot, M. (2017) · Molecular Syndromology · doi:10.1159/000456021 · Cited by 50
“Temporal-lobe specimens showed evidence for abnormalities of neuronal migration and structure, widespread astrogliosis, and reduced expression of Caspr2 [Strauss et al., 2006; Jackman et al., 2009].”
BackgroundInfluentialEdwards, D. R. V., Naj, A. C., Monda, K. L., North, K. E., Neuhouser, M. L., Magvanjav, O., Kusimo, I., Vitolins, M. Z., Manson, J. E., O’Sullivan, M. J., et al. (2012) · Human Genetics · doi:10.1007/s00439-012-1246-3 · Cited by 51
“Rare recessive genetic variation in CNTNAP2 has been associated with loss-offunction mutations in epilepsy, intellectual disability, and autism spectrum disorders, accompanied by a range of neuropathologic findings (Strauss et al. 2006).”
BackgroundSleep as a translationally-relevant endpoint in studies of autism spectrum disorder (ASD)
Missig, G., McDougle, C. J., & Carlezon, W. A. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0409-5 · Cited by 53
Muscatelli, F., Desarménien, M. G., Matarazzo, V. A., & Grinevich, V. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_16 · Cited by 53
“The Cntnap2 (Contactin-associated Protein-like 2) gene has been linked to ASD thanks to the discovery of a mutation in children with cortical dysplasia, focal epilepsy and presenting an ASD (Strauss et al. 2006), following genome-wide association studies and copy number variation analyses.”
BackgroundPRICKLE1 Interaction with SYNAPSIN I Reveals a Role in Autism Spectrum Disorders
Paemka, L., Mahajan, V. B., Skeie, J. M., Sowers, L. P., Ehaideb, S. N., Gonzalez‐Alegre, P., Sasaoka, T., Tao, H., Miyagi, A., Ueno, N., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080737 · Cited by 47
Veerappa, A. M., Saldanha, M., Padakannaya, P., & Ramachandra, N. B. (2013) · Journal of Human Genetics · doi:10.1038/jhg.2013.47 · Cited by 54
Genome-wide disruption of 5-hydroxymethylcytosine in a mouse model of autism
Papale, L. A., Zhang, Q., Li, S., Chen, K., Keleş, S., & Alisch, R. S. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv411 · Cited by 52
“Chemical labeling-based 5hmC enrichment was described previously (28).”
Vrečar, I., Innes, J., Jones, E. A., Kingston, H. M., Reardon, W., Kerr, B. A., Clayton‐Smith, J., & Douzgou, S. (2017) · Journal of Pediatric Genetics · doi:10.1055/s-0037-1601335 · Cited by 48
Flaherty, E. K., Deranieh, R. M., Artimovich, E., Lee, I. S., Siegel, A. J., Levy, D. L., Nestor, M. W., & Brennand, K. (2017) · Schizophrenia · doi:10.1038/s41537-017-0033-5 · Cited by 48
Kamdem, L. K., Hamilton, L. H., Cheng, C., Liu, W., Yang, W., Johnson, J. A., Pui, C., & Relling, M. V. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282fc5801 · Cited by 46
Doldur-Balli, F., Imamura, T., Veatch, O. J., Gong, N. N., Lim, D. C., Hart, M. P., Abel, T. G., Kayser, M. S., Brodkin, E. S., & Pack, A. I. (2022) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2022.101595 · Cited by 49
Cell Adhesion Molecules and Their Involvement in Autism Spectrum Disorder
Ye, H., Liu, J., & Wu, J. Y. (2010) · Neurosignals · doi:10.1159/000322543 · Cited by 48
“CNTNAP2 mutations were first identified in Amish individuals with recessive cortical dysplasia-focal epilepsy syndrome and language regression. Two thirds of the affected individuals also fulfill the criteria for ASD. Interestingly, the carboxyl-terminal truncation of CNTNAP2 is associated with severe autism with seiz…”
BackgroundJonsson, L., Zettergren, A., Pettersson, E., Hovey, D., Anckarsäter, H., Westberg, L., Lichtenstein, P., Lundström, S., & Melke, J. (2014) · Molecular Autism · doi:10.1186/2040-2392-5-55 · Cited by 44
“Although these findings primarily are based on rare mutations identified in ASD families [12-14], there is evidence for an influence of also common polymorphisms in ASD [3].”
BackgroundColl, M., Striano, P., Ferrer‐Costa, C., Campuzano, Ó., Matés, J., del Olmo, B., Iglesias, A., Pérez‐Serra, A., Mademont‐Soler, I., Picó, F., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189618 · Cited by 46
Zhou, W., Zhang, J., Li, Z., Lin, X., Li, J., Wang, S., Yang, C., Wu, Q., Ye, A. Y., Wang, M., et al. (2019) · Human Mutation · doi:10.1002/humu.23724 · Cited by 47
“In addition to typical symptoms, most patients with these two disorders have epilepsy (Le Meur et al., 2009; Strauss et al., 2006).”
BackgroundHome-cage hypoactivity in mouse genetic models of autism spectrum disorder
Angelakos, C. C., Tudor, J. C., Ferri, S. L., Jongens, T. A., & Abel, T. G. (2019) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2019.02.010 · Cited by 49
“Its deletion results in cortical dysplasia-focal epilepsy, seizures, and ASD in humans (Strauss et al., 2006), and seizures, social deficits, motor stereotypies, communication abnormalities, and interneuron reductions in mice (Peñagarikano et al., 2011).”
BackgroundInfluentialThe Legacy of the Benzodiazepine Receptor
Möhler, H. (2014) · Advances in pharmacology · doi:10.1016/bs.apha.2014.10.008 · Cited by 43
The genetics of Tourette disorder
State, M. W. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.01.007 · Cited by 40
Montojo, M. T., Petit‐Pedrol, M., Graus, F., & Dalmau, J. O. (2014) · Neurología · doi:10.1016/j.nrl.2013.12.007 · Cited by 43
Katidou, M., Vidaki, M., Strigini, M., & Karagogeos, D. (2008) · Biotechnology Journal · doi:10.1002/biot.200800281 · Cited by 43
Clinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders
Kim, K. C., Gonzales, E. L., Lázaro, M. T., Choi, C. S., Bahn, G. H., Yoo, H. J., & Shin, C. Y. (2016) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2016.061 · Cited by 47
“(Strauss et al., 2006).”
Contactin-1/F3 Regulates Neuronal Migration and Morphogenesis Through Modulating RhoA Activity
Chen, Y., Lu, I.-L., & Tsai, J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00422 · Cited by 46
“It has also been reported that mutations in human CNTNAP2 gene, which encodes a contactin-2 binding protein, is associated with seizures, mental retardation, schizophrenia and autism spectrum disorder (Strauss et al., 2006; Alarcon et al., 2008; Arking et al., 2008; Bakkaloglu et al., 2008; Friedman et al., 2008).”
BackgroundCao, F., Liu, J. J., Zhou, S., Cortez, M. A., Snead, O. C., Han, J., & Jia, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-17560-3 · Cited by 45
Casanova, M. F. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.04.014 · Cited by 44
“However, temporal lobe resection for epilepsy in patients with a homozygous mutation of CNTNAP2 shows abnormalities of neuronal migration [16].”
BackgroundTargeted next generation sequencing: the diagnostic value in early-onset epileptic encephalopathy
Gökben, S., Önay, H., Yılmaz, S., Atık, T., Serdaroğlu, G., Tekin, H. G., & Özkınay, F. (2016) · Acta Neurologica Belgica · doi:10.1007/s13760-016-0709-z · Cited by 42
“[23] reported a homozygous mutation CNTNAP2 in nine children with cortical dysplasia, focal epilepsy, relative”
BackgroundZebrafish, an In Vivo Platform to Screen Drugs and Proteins for Biomedical Use
Lee, H., Lin, C., & Tsai, H. (2021) · Pharmaceuticals · doi:10.3390/ph14060500 · Cited by 48
“Contactin-associated protein-like 2 (CNTNAP2) is found to be strongly related to autism and epilepsy in consanguineous families [69].”
BackgroundOne Community’s Effort to Control Genetic Disease
Strauss, K. A., Puffenberger, E. G., & Morton, D. H. (2012) · American Journal of Public Health · doi:10.2105/ajph.2011.300569 · Cited by 42
Self-citationRubio‐Marrero, E. N., Vincelli, G., Jeffries, C. M., Shaikh, T. R., Pakos, I. S., Ranaivoson, F. M., von Daake, S., Demeler, B., Jaco, A. D., Perkins, G. A., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.705681 · Cited by 42
“In vitro, we show that CASPR2–1253* folds properly, but it is secreted in the extracellular space, thus becoming non-functional due to the fact that the protein is no longer tethered to the cell membrane (7).”
ResultInfluentialCNTNAP2 polymorphisms and structural brain connectivity: A diffusion-tensor imaging study
von Hohenberg, C. C., Wigand, M. C. C., Kubicki, M. R., Leicht, G., Giegling, I., Karch, S., Hartmann, A. M., Konte, B., Friedl, M., Ballinger, T., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.07.002 · Cited by 43
“Another histological dimension that could potentially underly our findings are ectopic neurons present in white matter, which have been linked both to CNTNAP2 dysfunction (Penagarikano et al., 2011; Strauss et al., 2006) and schizophrenia (Eastwood & Harrison, 2003; Rioux et al., 2003).”
BackgroundInfluentialBaig, D. N., Yanagawa, T., & Tabuchi, K. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.10.006 · Cited by 47
Somatosensory cortex hyperconnectivity and impaired whisker-dependent responses in Cntnap2−/− mice
Balasco, L., Pagani, M., Pangrazzi, L., Chelini, G., Viscido, F., Chama, A. G. C., Galbusera, A., Provenzano, G., Gozzi, A., & Bozzi, Y. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105742 · Cited by 41
“2011), a phenotype shared with CDFE patients (Strauss et al., 2006).”
Epilepsy and neurodevelopmental disorders of language
Pal, D. K. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328344634a · Cited by 40
Altered social behavior in mice carrying a corticalFoxp2deletion
Medvedeva, V. P., Rieger, M. A., Vieth, B., Mombereau, C., Ziegenhain, C., Ghosh, T., Cressant, A., Enard, W., Granon, S., Dougherty, J. D., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy372 · Cited by 44
García‐Junco‐Clemente, P., Chow, D. K., Tring, E., Lázaro, M. T., Trachtenberg, J. T., & Golshani, P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309207110 · Cited by 46
Nudel, R., & Newbury, D. F. (2013) · Wiley Interdisciplinary Reviews Cognitive Science · doi:10.1002/wcs.1247 · Cited by 57
Defining the Contribution of CNTNAP2 to Autism Susceptibility
Sampath, S., Bhat, S., Gupta, S., O’Connor, A., West, A. B., Arking, D. E., & Chakravarti, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077906 · Cited by 45
“This gene was first identified in autism by linkage in a Old Order Amish family with an autosomal recessive founder null mutation leading to cortical dysplasia-focal epilepsy (CDFE; MIM 610042) characterized by the presence of neuronal migration abnormalities, seizures, intellectual disability, language regression, hy…”
BackgroundOxytocin and Animal Models for Autism Spectrum Disorder
Wagner, S., & Harony‐Nicolas, H. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_15 · Cited by 42
Transcriptional Dysregulation of Neocortical Circuit Assembly in ASD
Kwan, K. Y. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-418700-9.00006-x · Cited by 42
“Furthermore, the absence of contactin associated protein-like 2 (CNTNAP2, previously known as CASPR2), which has been implicated in ASD, leads to migration defects in both mice and humans (Peñagarikano et al., 2011; Strauss et al., 2006).”
BackgroundNguyen, L. H., & Anderson, A. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-21656-8 · Cited by 39
The juxtaparanodal proteins CNTNAP2 and TAG1 regulate diet-induced obesity
Buchner, D. A., Geisinger, J. M., Glazebrook, P. A., Morgan, M. G., Spiezio, S. H., Kaiyala, K. J., Schwartz, M. W., Sakurai, T., Furley, A. J., Kunze, D. L., et al. (2012) · Mammalian Genome · doi:10.1007/s00335-012-9400-8 · Cited by 43
“Mutations in Cntnap2 have been associated with speech disorders, autism, and epilepsy, although no previous association with metabolic disease has been described (Strauss et al. 2006; Alarcon et al. 2008; Arking et al. 2008; Bakkaloglu et al. 2008; Vernes et al. 2008; Newbury and Monaco 2010; O’Roak et al. 2011).”
InfluentialNeurogenomics of speech and language disorders: the road ahead
Deriziotis, P., & Fisher, S. E. (2013) · Genome biology · doi:10.1186/gb-2013-14-4-204 · Cited by 40
Association of genes with phenotype in autism spectrum disorder
Nisar, S., Hashem, S., Bhat, A. A., Syed, N., Yadav, S. K., Azeem, M. W., Shahab Uddin, M. S., Bagga, P., Reddy, R. D., & Haris, M. (2019) · Aging · doi:10.18632/aging.102473 · Cited by 41
“A subgroup of patients with Cortical Dysplasia-focal Epilepsy (CDFE), Rett Syndrome and Tuberous Sclerosis Syndrome have also found to express autistic behavior [15, 16].”
BackgroundWhite, S. A. (2009) · Brain and Language · doi:10.1016/j.bandl.2009.10.002 · Cited by 43
Park, G., Jeon, S. J., Ko, I. O., Park, J. H., Lee, K. C., Kim, M., Shin, C. Y., Kim, H., & Lee, Y. (2022) · Molecular Brain · doi:10.1186/s13041-022-00904-z · Cited by 42
“In several human cases with Cntnap2 mutations, focal malformation of brain regions or reduced long-range connectivity have been reported [38, 39].”
BackgroundRichard, A., Scheffer, I. E., & Wilson, S. J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.036 · Cited by 39
Varley, J. A., Vincent, A. C., & Irani, S. R. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7600-8 · Cited by 38
“Interestingly, a recessive non-coding mutation for CNTNAP2 causes cortical dysplasia focal epilepsy syndrome (CDFE), characterised by seizures, intellectual disability, hyperactivity, and in two-thirds of cases, autism [93].”
BackgroundThomas, A. M., Schwartz, M. D., Saxe, M., & Kilduff, T. S. (2017) · SLEEP · doi:10.1093/sleep/zsx138 · Cited by 37
Vecchia, E. D., Mortimer, N., Palladino, V. S., Kittel‐Schneider, S., Lesch, K., Reif, A., Schenck, A., & Norton, W. (2018) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000211 · Cited by 41
Genomics in the presurgical epilepsy evaluation
Moloney, P. B., Dugan, P. C., Widdess‐Walsh, P., Devinsky, O., & Delanty, N. (2022) · Epilepsy Research · doi:10.1016/j.eplepsyres.2022.106951 · Cited by 37
Watson, C. M., Crinnion, L. A., Tzika, A., Mills, A., Coates, A., Pendlebury, M., Hewitt, S. K., Harrison, S. M., Daly, C. L., Roberts, P., et al. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36679 · Cited by 37
“However, since no phenotypes have yet been reported in the heterozygous parents of children with CDFE/ PHLS1, it may be that the penetrance of heterozygous CNTNAP2 variants is low.”
BackgroundInfluentialThe CASPR2 cell adhesion molecule functions as a tumor suppressor gene in glioma
Bralten, L. B. C., Gravendeel, A. M., Kloosterhof, N. K., Sacchetti, A., Vrijenhoek, T., Veltman, J. A., van den Bent, M. J., Kros, J. M., Hoogenraad, C. C., Smitt, P. A. E. S., et al. (2010) · Oncogene · doi:10.1038/onc.2010.342 · Cited by 39
The genomic landscape of language: Insights into evolution
Mountford, H. S., & Newbury, D. F. (2017) · Journal of Language Evolution · doi:10.1093/jole/lzx019 · Cited by 35
Schneider, E., Hajj, N. E., Richter, S., Roche-Santiago, J., Nanda, I., Schempp, W., Riederer, P., Navarro, B., Bontrop, R. E., Kondova, I. I., et al. (2014) · Epigenetics · doi:10.4161/epi.27689 · Cited by 35
“Homozygous or compound heterozygous mutations cause severe epilepsy, mental retardation, and Pitt-Hopkins syndrome.(20,21) CNTNAP2 is physically and functionally linked to the forkhead box P2 (FOXP2) gene, which also has been implicated in speech and language development.”
BackgroundNew Ideas in Epilepsy Genetics
Gurnett, C. A., & Hedera, P. (2007) · Archives of Neurology · doi:10.1001/archneur.64.3.324 · Cited by 34
“A recent report described a homozygous mutation in contactin-associated protein-like 2 (CNTNAP2) in Amish childrenwith intractable, focal epilepsy,developmental regression, and cortical dysplasia.(14) The protein encoded by CNTNAP2clustersvoltage-gatedpotassiumchannels(Kv1.”
BackgroundIs focal cortical dysplasia sporadic? Family evidence for genetic susceptibility
Leventer, R. J., Jansen, F. E., Mandelstam, S. A., Ho, A., Mohamed, I., Sarnat, H. B., Kato, M., Fukasawa, T., Saitsu, H., Matsumoto, N., et al. (2014) · Epilepsia · doi:10.1111/epi.12533 · Cited by 33
“Mutations in CNTNAP2 have been reported in children with FCD from Old Order Amish pedigrees.(3) These children differed from most patients with FCD because of mental retardation and macrocephaly, and the imaging findings and histology were not typical of either FCD type I or FCD type II.”
BackgroundPrüß, H., & Lennox, B. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-313000 · Cited by 33
Paternò, R., Casalia, M. L., & Baraban, S. C. (2019) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2019.12.015 · Cited by 37
Neurobiological Mechanisms of Autism Spectrum Disorder and Epilepsy, Insights from Animal Models
Sierra-Arregui, T., Llorente, J., Mínguez, P., Tønnesen, J., & Peñagarikano, O. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.02.043 · Cited by 35
Pharmacoresponse in Genetic Generalized Epilepsy: A Genome-Wide Association Study
Wolking, S., Schulz, H., Nies, A. T., McCormack, M., Schaeffeler, E., Auce, P., Avberšek, A., Becker, F., Klein, K. M., Krenn, M., et al. (2020) · Pharmacogenomics · doi:10.2217/pgs-2019-0179 · Cited by 34
Is Focal Cortical Dysplasia/Epilepsy Caused by Somatic MTOR Mutations Always a Unilateral Disorder?
Guerrini, R., Cavallin, M., Pippucci, T., Rosati, A., Bisulli, F., Dimartino, P., Barba, C., Garbelli, R., Buccoliero, A. M., Tassi, L., et al. (2020) · Neurology Genetics · doi:10.1212/nxg.0000000000000540 · Cited by 35
George-Hyslop, F. S., Haneklaus, M., Kivisild, T., & Livesey, F. J. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.03.014 · Cited by 38
Distribution of language‐related Cntnap2 protein in neural circuits critical for vocal learning
Condro, M. C., & White, S. A. (2013) · The Journal of Comparative Neurology · doi:10.1002/cne.23394 · Cited by 36
“A majority of affected children meet criteria for autism spectrum disorder (ASD), of which language impairment is a core deficit (Strauss et al., 2006).”
Background
Metadata
- Authors
- Strauss, K. A., Puffenberger, E. G., Huentelman, M. J., Gottlieb, S., Dobrin, S. E., Parod, J. M., Stephan, D. A., & Morton, D. H.
- Affiliations
- Clinic for Special Children (US)
- Translational Genomics Research Institute (US)
- Lancaster General Hospital (US)
- Marshfield Clinic Research Foundation (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-03-30
- Volume
- 354
- Issue
- 13
- Pages
- 1370-1377
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2022498096
- Cited by
- 630
- References
- 24
- Citations by year
- 2026: 17 · 2025: 24 · 2024: 17 · 2023: 28 · 2022: 24 · 2021: 25 · 2020: 29 · 2019: 31 · 2018: 37 · 2017: 47 · 2016: 33 · 2015: 45 · 2014: 29 · 2013: 43 · 2012: 47
- FWCI
- 15.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- CNTNAP2, nodes of Ranvier, cortical dysplasia, macrocephaly, language regression, intellectual disability, seizure recurrence, resective surgery, astrocyte activation, Old Order Amish
- MeSH terms
- Child, Child, Preschool, Electroencephalography, Epilepsies, Partial, Homozygote, Humans, Membrane Proteins, Mutation, Nerve Tissue Proteins, Phenotype, Reflex, Stretch, Seizures, Temporal Lobe, Gene Expression, Magnetic Resonance Angiography, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.